Positive

Social media startup tackles mental health and Gen Z demand for more positive social networking through poetry

Social media startup tackles mental health and Gen Z demand for more positive social networking through poetry

Poetizer, Europe’s First “Born” Social Network Focuses on Poetry for Creativity, Healing and Community, Launches Green Publishing Technology PRAGUE, October 5, 2022 /PRNewswire/ — Do a quick search on the internet and you’ll quickly discover the return of poetry and its mental health benefits. As more and more people leave traditional social media platforms, especially …

Social media startup tackles mental health and Gen Z demand for more positive social networking through poetry Read More »

Nonprofit hospitals expand charitable care, but not all changes are positive

Nonprofit hospitals expand charitable care, but not all changes are positive

Photo; The Good Brigade/Getty Images About 84% of nonprofit hospitals updated their charitable care policies from 2019 to 2021, during the height of the COVID-19 pandemic, and according to findings published in JAMA Network Open, these updated policies have resulted in mostly positive changes. However, restrictions in charitable care and unclear eligibility criteria are still …

Nonprofit hospitals expand charitable care, but not all changes are positive Read More »

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis

SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc. today announced positive interim clinical results from an ongoing Phase 2 study of its lead clinical development candidate, pegsitacianine, for the detection of residual disease after cytoreductive surgery. (CRS). Study results were presented by Patrick Wagner, MD, Department of Surgical Oncology, Allegheny Health Network Cancer Institute, during an oral presentation …

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an Adjunct to Cytoreductive Surgery for Peritoneal Carcinomatosis Read More »

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab

The ROSALIA study met the primary endpoints, confirming that the proposed biosimilar denosumab matches the reference product in terms of pharmacokinetics, pharmacodynamics, efficacy, safety and immunogenicity in postmenopausal women with osteoporosis Osteoporosis is responsible for 8.9 million bone fractures a year, including debilitating hip fractures – a number that is expected to rise dramatically over …

Sandoz Announces Further Progress in its Biosimilars Portfolio, with the Publication of Positive Results from the Integrated Phase I/III Clinical Trial of Denosumab Read More »